New Tool Guides Clinicians to Identify and Treat Patients at Risk for Monkeypox Virus
The clinical decision support system is embedded in the electronic health record for ease of use.
About Erica Shenoy, MD, PhD
Dr. Shenoy is an infectious diseases physician at Massachusetts General Hospital (MGH) and Medical Director of Infection Control for Mass General Brigham. As Medical Director, Dr. Shenoy is responsible for the development and implementation of infection control strategies, policies, and measurement across the Mass General Brigham system. She is an Associate Professor of Medicine at Harvard Medical School.
At MGH, she cares patients in outpatient clinic and the inpatient consult service. She serves as Associate Chief of the MGH Infection Control Unit and is Medical Director of the Emerging Special Pathogens Treatment Center at MGH, a federally-funded center with expertise in preparedness and response for emerging pathogens. In this role, she has responsibility for development and implementation of a comprehensive infection prevention program for the MGH Biocontainment Unit, the Special Pathogens Unit, and the Special Pathogens Program.
Dr. Shenoy is a Fellow in both the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). She has served on the Guidelines Committee of SHEA and currently Chair of SHEA’s Public Policy and Government Affairs Committee and co-chair of the Sterilization and High-Level Disinfection guidelines committee. An active member of IDSA, she previously served on the IDSA Antimicrobial Resistance Committee.
Clinical Interests:
- AIDS and HIV infection
- Hospital acquired infections
- Infectious diseases
- MRSA
- Multi-drug resistant infections
- Non Tuberculous Mycobacterial infections
- Prevention
- Tuberculosis (TB) including drug-resistant TB
- Vaccines and immunizations
- VRE
Treats:
- Adult
Languages:
- French, Spanish
Locations
Mass General Infectious Diseases
55 Fruit St.
Boston, MA 02114
Phone: 617-726-3906
Medical Education
- M.D.; Ph.D., Harvard Medical School
- Residency, Massachusetts General Hospital*
- Fellowship, Massachusetts General Hospital*
American Board Certifications
- Infectious Disease, American Board of Internal Medicine
- Internal Medicine, American Board of Internal Medicine
Accepted Insurance Plans
- Aetna Health Inc.
- Beech Street
- Blue Cross Blue Shield - Blue Care 65
- Blue Cross Blue Shield - Indemnity
- Blue Cross Blue Shield - Managed Care
- Blue Cross Blue Shield - Partners Plus
- BMC HealthNet Mass Health MCO/ACO
- Centene/Celticare
- Cigna (PAL #'s)
- Commonwealth Care Alliance
- Fallon Community HealthCare
- Great-West Healthcare (formally One Health Plan)
- Harvard Pilgrim Health Plan - ACD
- Harvard Pilgrim Health Plan - PBO
- Health Care Value Management (HCVM)
- Humana/Choice Care PPO
- Maine Community Health Options (MCHO)
- Mass General Brigham Health Plan - ACD
- Mass General Brigham Health Plan - PBO
- MassHealth
- Medicare
- Medicare - ACD
- Medicare ACO - ACD
- Medicare ACO - PBO
- OSW - Maine
- OSW - New Hampshire
- OSW - Rhode Island
- OSW - Vermont
- Private Health Care Systems (PHCS)
- Senior Whole Health
- TriCare
- Tufts Health Plan
- Unicare
- United Healthcare (non-HMO) - ACD
- United Healthcare (non-HMO) - PBO
- Well Sense Pediatrics
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Research
Dr. Shenoy?s research has evaluated the clinical, operational and economic impact of infection control strategies for multi-drug resistant pathogens and prevention of hospital acquired infections through clinical studies and mathematical modeling, use of electronic health records for surveillance, and applied machine-learning techniques to create risk prediction models for infectious diseases. Dr. Shenoy is the Principal Investigator on a five-year CDC-funded grant developing and deploying novel approaches to infection prevention and control education and workflows. She has taught and published on detection and prevention of nosocomial infections and interventions, evaluation and management of HCP exposure to infectious agents, as well as pre- and post-exposure prophylaxis of HCP.